<i>BRCA1/2</i>mutations and survival of high-grade endometrioid endometrial cancer

Yibo Dai(Peking University), Zhiqi Wang(Academy of Medical Sciences), Jingyuan Wang(Eli Lilly (United States)), Luyang Zhao(Chinese PLA General Hospital)
Gynecology and Obstetrics Clinical Medicine
December 11, 2020
Cited by 2


Related Papers